Invesco’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.05M | Sell |
251,851
-2,173
| -0.9% | -$17.7K | ﹤0.01% | 2571 |
|
2025
Q1 | $1.99M | Buy |
254,024
+50,037
| +25% | +$393K | ﹤0.01% | 2545 |
|
2024
Q4 | $3.04M | Buy |
203,987
+35,905
| +21% | +$535K | ﹤0.01% | 2454 |
|
2024
Q3 | $2.57M | Sell |
168,082
-14,358
| -8% | -$220K | ﹤0.01% | 2501 |
|
2024
Q2 | $2.78M | Sell |
182,440
-8,243
| -4% | -$126K | ﹤0.01% | 2453 |
|
2024
Q1 | $3.6M | Sell |
190,683
-1,947
| -1% | -$36.8K | ﹤0.01% | 2413 |
|
2023
Q4 | $3.68M | Sell |
192,630
-40,174
| -17% | -$767K | ﹤0.01% | 2389 |
|
2023
Q3 | $4.18M | Sell |
232,804
-16,361
| -7% | -$294K | ﹤0.01% | 2294 |
|
2023
Q2 | $5.06M | Sell |
249,165
-33,954
| -12% | -$690K | ﹤0.01% | 2229 |
|
2023
Q1 | $5.16M | Buy |
283,119
+10,841
| +4% | +$198K | ﹤0.01% | 2195 |
|
2022
Q4 | $5.63M | Buy |
272,278
+5,764
| +2% | +$119K | ﹤0.01% | 2178 |
|
2022
Q3 | $6.97M | Sell |
266,514
-74,250
| -22% | -$1.94M | ﹤0.01% | 2014 |
|
2022
Q2 | $8.64M | Buy |
340,764
+47,290
| +16% | +$1.2M | ﹤0.01% | 1945 |
|
2022
Q1 | $9.26M | Buy |
293,474
+94,844
| +48% | +$2.99M | ﹤0.01% | 1997 |
|
2021
Q4 | $8.04M | Sell |
198,630
-26,054
| -12% | -$1.05M | ﹤0.01% | 2136 |
|
2021
Q3 | $7.83M | Buy |
224,684
+6,331
| +3% | +$221K | ﹤0.01% | 2139 |
|
2021
Q2 | $6M | Sell |
218,353
-79,524
| -27% | -$2.18M | ﹤0.01% | 2348 |
|
2021
Q1 | $8.36M | Sell |
297,877
-6,881
| -2% | -$193K | ﹤0.01% | 2063 |
|
2020
Q4 | $7.91M | Buy |
304,758
+18,492
| +6% | +$480K | ﹤0.01% | 1926 |
|
2020
Q3 | $4.91M | Sell |
286,266
-5,180
| -2% | -$88.8K | ﹤0.01% | 2013 |
|
2020
Q2 | $7.21M | Buy |
291,446
+5,155
| +2% | +$128K | ﹤0.01% | 1806 |
|
2020
Q1 | $3.97M | Buy |
+286,291
| New | +$3.97M | ﹤0.01% | 2008 |
|